References
- Abdul-Hamid, E., R. Roy, R. T. McKay, L. Tenori, E. Saccenti, G. A. Nagana Gowda, D. Raftery, F. Alahmari, L. Jaremko, M. Jaremko, et al. 2019. NMR Spectroscopy for metabolomics research. Metabolites 9 (7):123. doi:https://doi.org/10.3390/metabo9070123.
- Ahn, Y., M. Narous, R. Tobias, J. M. Rho, and R. Mychasiuk. 2014. The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder. Dev. Neurosci 36 (5):371–80. doi:https://doi.org/10.1159/000362645.
- Akande, M. G., Y. O. Aliu, S. F. Ambali, and J. O. Ayo. 2014. Taurine mitigates cognitive impairment induced by chronic co-exposure of male Wistar rats to chlorpyrifos and lead acetate. Environ. Toxicol. Pharmacol. 37 (1):315–25. doi:https://doi.org/10.1016/j.etap.2013.11.023.
- Baker, G. A., R. L. Bromley, M. Briggs, C. P. Cheyne, M. J. Cohen, M. Garcia-Finana, A. Gummery, R. Kneen, D. W. Loring, and G. Mawer; Baker, G. A., R. L. Bromley, M. Briggs, C. P. Cheyne, M. J. Cohen, M. García-Fiñana, A. Gummery, R. Kneen, D. W. Loring, G. Mawer, K. J. Meador, R. Shallcross, J. Clayton-Smith, and Liverpool and Manchester Neurodevelopment Group. 2015. IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study. Neurology 84 (4):382–90. doi:https://doi.org/10.1212/WNL.0000000000001182.
- Baron-Cohen, S., F. J. Scott, C. Allison, J. Williams, P. Bolton, F. E. Matthews, and C. Brayne. 2009. Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiat 194 (6):500–09. doi:https://doi.org/10.1192/bjp.bp.108.059345.
- Binkerd, P. E., J. M. Rowland, H. Nau, A. G. Hendrickx, J. M. Rowland, H. Nau, A. G. Hendrickx, H. Nau, A. G. Hendrickx, and A. G. Hendrickx. 1988. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam Appl Toxicol 11 (3):485–93. doi:https://doi.org/10.1016/0272-0590(88)90112-1.
- Bonvallot, N., M. Tremblay-Franco, C. Chevrier, C. Canlet, L. Debrauwer, J. –. P. Cravedi, and S. Cordier. 2014. Potential input from metabolomics for exploring and understanding the links between environment and health. J Toxicol Environ Health B 17 (1):21–44. doi:https://doi.org/10.1080/10937404.2013.860318.
- Chauhan, A., and V. Chauhan. 2006. Oxidative stress in autism. Pathophysiology 13(3):171–81. Epub 2006 Jun 12. doi:https://doi.org/10.1016/j.pathophys.2006.05.007.
- Chen, Q., Y. Qiao, X. Xu, Y. Tao, and X. You. 2019. Urine organic acids as potential biomarkers for autism-spectrum disorder in Chinese children. Front. Cell Neurosci 13(150): eCollection. doi:https://doi.org/10.3389/fncel.2019.00150.
- Christensen, J., T. K. Grønborg, M. J. Sørensen, D. Schendel, E. T. Parner, L. H. Pedersen, and M. Vestergaard. 2013. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. J. Am. Med. Assoc. 309 (16):1696–703. doi:https://doi.org/10.1001/jama.2013.2270.
- Clark-Taylor, T., and B. E. Clark-Taylor. 2004. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial β-oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 62 (6):970–75. doi:https://doi.org/10.1016/j.mehy.2004.01.011.
- Dawson, G., E. J. Jones, K. Merkle, K. Venema, R. Lowy, S. Faja, D. Kamara, M. Murias, J. Greenson, J. Winter, et al. 2012. Early behavioral intervention is associated with normalized brain activity in young children with autism. J. Am. Acad. Child. Adolesc. Psychiat 51 (11):1150–59. doi:https://doi.org/10.1016/j.jaac.2012.08.018.
- de Theije, C. G., H. Wopereis, M. Ramadan, T. van Eijndthoven, J. Lambert, J. Knol, J. Garssen, A. D. Kraneveld, and R. Oozeer. 2014. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav. Immun 37:197–206. Epub 2013 Dec 11. doi:https://doi.org/10.1016/j.bbi.2013.12.005.
- Dieme, B., S. Mavel, H. Blasco, G. Tripi, F. Bonnet-Brilhault, J. Malvy, C. Bocca, C. R. Andres, L. Nadal-Desbarats, and P. Emond. 2015. Metabolomics study of urine in autism spectrum disorders using a multiplatform analytical methodology. . Journal of Proteome Research 14 (12):5273–82. doi:https://doi.org/10.1021/acs.jproteome.5b00699.
- Emond, P., S. Mavel, N. Aidoud, L. Nadal-Desbarats, F. Montigny, F. Bonnet-Brilhault, C. Barthélémy, M. Merten, P. Sarda, F. Laumonnier, et al. 2013. GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal. Bioanal. Chem. 405 (15):5291–300. doi:https://doi.org/10.1007/s00216-013-6934-x.
- Engelborghs, S., B. Marescau, and P. P. De Deyn. 2003. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson’s disease. Neurochem. Res. 28 (8):1145–50. doi:https://doi.org/10.1023/a:1024255208563.
- Fiorentino, M., A. Sapone, S. Senger, S. S. Camhi, S. M. Kadzielski, T. M. Buie, D. L. Kelly, Cascella, N. Fasano, and A. 2016. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol. Autism 7(49): eCollection. doi:https://doi.org/10.1186/s13229-016-0110-z.
- Ghaziuddin, M., and M. Al-Owain. 2013. Autism spectrum disorders and inborn errors of metabolism: An update. Pediatr. Neurol 49 (4):232–36. doi:https://doi.org/10.1016/j.pediatrneurol.2013.05.013.
- Giulivi, C., Y. F. Zhang, A. Omanska-Klusek, C. Ross-Inta, S. Wong, I. Hertz-Picciotto, F. Tassone, and I. N. Pessah. 2010. Mitochondrial dysfunction in autism. J. Am. Med. Assoc. 304 (21):2389–96. doi:https://doi.org/10.1001/jama.2010.1706.
- Glickstein, M., F. Sultan, and J. Voogd. 2011. Functional localization in the cerebellum. Cortex 47 (1):59–80. doi:https://doi.org/10.1016/j.cortex.2009.09.001.
- Graham, S. F., O. P. Chevallier, P. Kumar, O. Türkoğlu, and R. O. Bahado-Singh. 2016. High resolution metabolomic analysis of ASD human brain uncovers novel biomarkers of disease. Metabolomics 12 (4):62. doi:https://doi.org/10.1007/s11306-016-0986-9.
- Harris, J. J., R. Jolivet, and D. Attwell. 2012. Synaptic energy use and supply. Neuron 75 (5):762–77. doi:https://doi.org/10.1016/j.neuron.2012.08.019.
- Hill, D. S., R. Cabrera, D. W. Schultz, H. Zhu, W. Lu, R. H. Finnell, and B. J. Wlodarczyk. 2015. Autism-like behavior and epigenetic changes associated with autism as consequences of in utero exposure to environmental pollutants in a mouse model. Behav. Neurol 426263. doi:https://doi.org/10.1155/2015/426263.
- Ingram, J. L., S. M. Peckham, B. Tisdale, and P. M. Rodier. 2000. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol 22 (3):319–24. doi:https://doi.org/10.1016/s0892-0362(99)00083-5.
- Jang, H. J., J. D. Lee, H. S. Jeon, A.-R. Kim, S. Kim, H.-S. Lee, and K.-B. Kim. 2018. Metabolic profling of eccentric exercise-induced muscle damage in human urine. Toxicol. Res. 34 (3):199–210. doi:https://doi.org/10.5487/TR.2018.34.3.199.
- Kanavin, O. J., B. Woldseth, E. Jellum, B. Tvedt, B. S. Andresen, and P. Stromme. 2007. 2-Methylbutyryl-CoA dehydrogenase deficiency associated with autism and mental retardation: A case report. J. Med. Case Rep 1 (1):98. doi:https://doi.org/10.1186/1752-1947-1-98.
- Kataoka, S., K. Takuma, Y. Hara, Y. Maeda, Y. Ago, and T. Matsuda. 2013. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol 16 (1):91–103. doi:https://doi.org/10.1017/S1461145711001714.
- Kim, J.-W., K. Park, R. J. Kang, E. L. T. Gonzales, D. G. Kim, H. A. Oh, H. Seung, M. J. Ko, K. J. Kwon, K. C. Kim, et al. 2019. Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism. Neuropsychopharmacology 44 (2):314–23. doi:https://doi.org/10.1038/s41386-018-0098-5.
- Kim, K. B., and B. M. Lee. 2009. Metabolomics, a new promising technology for toxicological research. Toxicol. Res. 25 (2):59–69. doi:https://doi.org/10.5487/TR.2009.25.2.059.
- Kim, K. C., D.-K. Lee, H. S. Go, P. Kim, C. S. Choi, J.-W. Kim, S. J. Jeon, M.-R. Song, and C. Y. Shin. 2014. Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol. Neurobiol. 49 (1):512–28. doi:https://doi.org/10.1007/s12035-013-8535-2.
- Kim, K. C., E. L. Gonzales, M. T. Lázaro, C. S. Choi, G. H. Bahn, H. J. Yoo, and C. Y. Shin. 2016. Clinical and neurobiological relevance of current animal models of autism spectrum disorders. Biomol. Ther (Seoul) 24 (3):207–43. doi:https://doi.org/10.4062/biomolther.2016.061.
- Kim, K. C., P. Kim, H. S. Go, C. S. Choi, J. H. Park, H. J. Kim, S. J. Jeon, P. I. C. Dela, S. H. Han, J. H. Cheong, et al. 2013. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J. Neurochem. 124 (6):832–43. doi:https://doi.org/10.1111/jnc.12147.
- Kim, K. C., P. Kim, H. S. Go, C. S. Choi, S. I. Yang, J. H. Cheong, C. Y. Shin, and K. H. Ko. 2011. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett 201 (2):137–42. doi:https://doi.org/10.1016/j.toxlet.2010.12.018.
- Kim, K.-B., J.-Y. Yang, S. J. Kwack, K. L. Park, H. S. Kim, D. H. Ryu, Y.-J. Kim, G.-S. Hwang, and B. M. Lee. 2010. Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model. J. Toxicol. Environ. Health Part A 73 (21–22):1420–30. doi:https://doi.org/10.1080/15287394.2010.511545.
- Kiseleva, M., L. Yagovkina, A. Ovsyannikova, and S. Baranov. 2020. Statistical analysis of the prevalence of persons with autism in modern society, 582–86. Ecological-Socio-Economic Systems: Models of Competition and Cooperation (ESES 2019). Paris: Atlantis Press.
- Kumar, H., B. M. Sharma, and B. Sharma. 2015. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochem. Int 91:34–45. Epub 2015 Oct 20. doi:https://doi.org/10.1016/j.neuint.2015.10.007.
- Kurochkin, I., E. Khrameeva, A. Tkachev, V. Stepanova, A. Vanyushkina, E. Stekolshchikova, Q. Li, D. Zubkov, P. Shichkova, T. Halene, et al. 2019. Metabolome signature of autism in the human prefrontal cortex. Commun. Biol 2 (1):234. doi:https://doi.org/10.1038/s42003-019-0485-4.
- Kuwabara, H., H. Yamasue, S. Koike, H. Inoue, Y. Kawakubo, M. Kuroda, Y. Takano, N. Iwashiro, T. Natsubori, Y. Aoki, et al. 2013. Altered metabolites in the plasma of autism spectrum disorder: A capillary electrophoresis time-of-flight mass spectroscopy study. PLoS One 8 (9):e73814. doi:https://doi.org/10.1371/journal.pone.0073814.
- Lee, J. D., H. Y. Kim, J. J. Park, S. B. Oh, H. Goo, K. J. Cho, S. Kim, and K. B. Kim. 2021. Metabolomics approach to biomarkers of dry eye disease using 1H-NMR in rats. J. Toxicol. Environ. Health Part A 84 (8):313–30. doi:https://doi.org/10.1080/15287394.2020.1867274.
- Lee, J. D., H. Y. Kim, K. Kang, H. G. Jeong, M. K. Song, I. H. Tae, S. H. Lee, H. R. Kim, K. Lee, S. Chae, et al. 2020. Integration of transcriptomics, proteomics and metabolomics identifies biomarkers for pulmonary injury by polyhexamethylene guanidine phosphate (PHMG-p), a humidifier disinfectant, in rats. Arch. Toxicol. 94 (3):887–909. doi:https://doi.org/10.1007/s00204-020-02657-x.
- Li, P., and Z.-H. Li. 2021. Neurotoxicity and physiological stress in brain of zebrafish chronically exposed to tributyltin. J. Toxicol. Environ. Health Part A 84 (1):20–30. doi:https://doi.org/10.1080/15287394.2020.1828209.
- Lucchina, L., and A. M. Depino. 2014. Altered peripheral and central inflammatory responses in a mouse model of autism. Autism Res 7 (2):273–89. doi:https://doi.org/10.1002/aur.1338.
- Mabunga, D. F., E. L. Gonzales, J. W. Kim, K. C. Kim, and C. Y. Shin. 2015. Exploring the validity of valproic acid animal model of autism. Exp. Neurobiol 24 (4):285–300. doi:https://doi.org/10.5607/en.2015.24.4.285.
- Mavel, S., L. Nadal-Desbarats, H. Blasco, F. Bonnet-Brilhault, C. Barthelemy, F. Montigny, P. Sarda, F. Laumonnier, P. Vourc'h, C. R. Andres, and P. Emond. 2013. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders. Talanta 114:95–102. doi:https://doi.org/10.1016/j.talanta.2013.03.064.
- Menzie, J. C., P. H. Prentice, and J.-Y. Wu. 2014. Taurine and central nervous system disorders. Amino Acids 46 (1):31–46. doi:https://doi.org/10.1007/s00726-012-1382-z.
- Mosconi, M. W., Z. Wang, L. M. Schmitt, P. Tsai, and J. A. Sweeney. 2015. The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders. Front. Neurosci. 9:296. doi:https://doi.org/10.3389/fnins.2015.00296.
- Na, J., J. Zhang, Y. L. Choe, C. S. Lim, and Y. H. Park. 2021. An in vitro study on the differentiated metabolic mechanism of chloroquine-resistant Plasmodium falciparum using high-resolution metabolomics. J. Toxicol. Environ. Health Part A. 84. doi: https://doi.org/10.1080/15287394.2021.1944945. Epub 2021. Aug 05.
- Orozco, J. S., I. Hertz-Picciotto, L. Abbeduto, and C. M. Slupsky. 2019. Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome. Transl. Psychiat 9 (1):243. doi:https://doi.org/10.1038/s41398-019-0578-3.
- Poling, J. S., R. E. Frye, J. Shoffner, and A. W. Zimmerman. 2006. Developmental regression and mitochondrial dysfunction in a child with autism. J. Child. Neurol 21 (2):170–72. doi:https://doi.org/10.1177/08830738060210021401.
- Ramsay, J., J. Morton, M. Norris, and S. Kanungo. 2018. Organic acid disorders. Ann. Transl. Med. 6 (24):472. doi:https://doi.org/10.21037/atm.2018.12.39.
- Rangel-Huerta, O. D., A. Gomez-Fernandez, M. J. de la Torre-Aguilar, A. Gil, J. L. Perez-Navero, K. Flores-Rojas, P. Martin-Borreguero, and M. Gil-Campos. 2019. Metabolic profiling in children with autism spectrum disorder with and without mental regression: Preliminary results from a cross-sectional case-control study. Metabolomics 15 (7):99. doi:https://doi.org/10.1007/s11306-019-1562-x.
- Rice, D., S. Jr, and Barone. 2000. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl 3):511–33. doi:https://doi.org/10.1289/ehp.00108s3511.
- Rodier, P. M., J. L. Ingram, B. Tisdale, S. Nelson, and J. Romano. 1996. Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol 370 (2):247–61. doi:https://doi.org/10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2.
- Rosique, C., D. Lebsir, P. Lestaevel, S. Benatia, P. Guigon, F. Caire-Maurisier, M. Benderitter, D. Bennouna, M. Souidi, and J.-C. Martin. 2019. Assessment of the effects of repeated doses of potassium iodide intake during pregnancy on male and female rat offspring using metabolomics and lipidomics. J. Toxicol. Environ. Health Part A 82 (10):603–15. doi:https://doi.org/10.1080/15287394.2019.1625474.
- Rossignol, D. A., and R. E. Frye. 2014. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol. 5:150. doi:https://doi.org/10.3389/fphys.2014.00150.
- Roullet, F. I., L. Wollaston, D. Decatanzaro, and J. A. Foster. 2010. Behavioural and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 170 (2):514–22. doi:https://doi.org/10.1016/j.neuroscience.2010.06.069.
- Rubio-Gozalbo, M. E., M. Haskovic, A. M. Bosch, B. Burnyte, A. I. Coelho, D. Cassiman, M. L. Couce, C. Dawson, D. Demirbas, T. Derks, et al. 2019. The natural history of classic galactosemia: Lessons from the GalNet registry. Orphanet. J. Rare. Dis 14 (86). doi: https://doi.org/10.1186/s13023-019-1047-z.
- Ryu, S. H., J. D. Lee, J. W. Kim, S. Kim, S. Kim, and K.-B. Kim. 2019. 1</sup>H NMR toxicometabolomics following cisplatin-induced nephrotoxicity in male rats. J. Toxicol. Sci. 44 (1):57–71. doi:https://doi.org/10.2131/jts.44.57.
- Ryu, S. H., J. W. Kim, D. Yoon, S. Kim, and K. B. Kim. 2018. Serum and urine toxicometabolomics following gentamicin-induced nephrotoxicity in male Sprague-Dawley rats. J. Toxicol. Environ. Health Part A 81 (11):408–20. doi:https://doi.org/10.1080/15287394.2018.1451180.
- Schneider, T., and R. Przewlocki. 2005. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 30 (1):80–89. doi:https://doi.org/10.1038/sj.npp.1300518.
- Shin, K. M., G. D. Lim, S. Hong, S. N. Kim, S. R. Hwang, J. H. Lee, S. J. Sin, A. R. Cho, Y. G. Kim, Gautam, et al. 2021. Exposure to lead on expression levels of brain immunoglobulins, inflammatory cytokines, and brain-derived neurotropic factor in fetal and postnatal mice with autism-like characteristics. Journal of Toxicology and Environmental Health, Part A. doi: https://doi.org/10.1080/15287394.2021.1945985. Epub 2021. Aug 05. 1–10
- Shivaraj, M. C., G. Marcy, G. Low, J. R. Ryu, X. Zhao, F. J. Rosales, and E. L. K. Goh. 2012. Taurine induces proliferation of neural stem cells and synapse development in the developing mouse brain. PLoS One 7 (8):e42935. doi:https://doi.org/10.1371/journal.pone.0042935.
- Spisák, T., V. Román, E. Papp, R. Kedves, K. Sághy, C. K. Csölle, A. Varga, D. Gajári, G. Nyitrai, Z. Spisák, et al. 2019. Purkinje cell number-correlated cerebrocerebellar circuit anomaly in the valproate model of autism. Sci. Rep. 9 (1):9225. doi:https://doi.org/10.1038/s41598-019-45667-1.
- Suarez, L. M., M. D. Munoz, R. M. D. Rio, and J. M. Solis. 2016. Taurine content in different brain structures during ageing: Effect on hippocampal synaptic plasticity. Amino Acids 48 (5):1199–208. doi:https://doi.org/10.1007/s00726-015-2155-2.
- Sun, R., J. Zhang, M. Xiong, Y. Chen, L. Yin, and Y. Pu. 2012. Metabonomics biomarkers for subacute toxicity screening for benzene exposure in mice. J. Toxicol. Environ. Health Part A 75 (18):1163–73. doi:https://doi.org/10.1080/15287394.2012.699858.
- Tărlungeanu, D. C., E. Deliu, C. P. Dotter, M. Kara, P. C. Janiesch, M. Scalise, M. Galluccio, M. Tesulov, E. Morelli, F. M. Sonmez, K. Bilguvar, R. Ohgaki, Y. Kanai, A. Johansen, S. Esharif, T. Ben-Omran, M. Topcu, A. Schlessinger, C. Indiveri, K. E. Duncan, A. O. Caglayan, M. Gunel, J. G. Gleeson, and G. Novarino. 2016. Impaired amino acid transport at the blood brain barrier Iis a cause of autism spectrum disorder. Cell 67 (6):1481–94. doi:https://doi.org/10.1016/j.cell.2016.11.013.
- Toczylowska, B. E., Z. P. Senator, and J. W. Lazarewicz. 2020. Hippocampal metabolite profiles in two rat models of autism: NMR-based metabolomics studies. Mol. Neurobiol. 57 (7):3089–105. doi:https://doi.org/10.1007/s12035-020-01935-0.
- Tsai, -S.-S., Y.-W. Chiu, Y.-H. Weng, and C.-Y. Yang. 2021. Relationship between fine particulate air pollution and hospital administrations for depression: A case-crossover study in Taipei. J. Toxicol. Environ. Health Part A 84 (17):702–09. doi:https://doi.org/10.1080/15287394.2021.1932652.
- Vorhees, C. V. 1987. Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 35 (2):195–202. doi:https://doi.org/10.1002/tera.1420350205.
- Wehrli, S. L., G. T. Berry, M. Palmieri, A. Mazur, L. Elsas, and S. Segal. 1997. Urinary galactonate in patients with galactosemia: Quantitation by nuclear magnetic resonance spectroscopy. Pediatric Research 42 (6):855–61. S. 3rd. Segal. doi:https://doi.org/10.1203/00006450-199712000-00022.
- West, P. R., D. G. Amaral, P. Bais, A. M. Smith, L. A. Egnash, M. E. Ross, J. A. Palmer, B. R. Fontaine, K. R. Conard, B. A. Corbett, et al. 2014. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. PLoS One 9 (11):e112445. doi:https://doi.org/10.1371/journal.pone.0112445.
- Williams, G., J. King, M. Cunningham, M. Stephan, B. Kerr, and J. H. Hersh. 2001. Fetal valproate syndrome and autism: Additional evidence of an association. Dev. Med. Child. Neurol 43 (3):202–06. doi:https://doi.org/10.1017/s0012162201211542.
- Wilson, A., C. A. Velasco, G. W. Herbert, S. N. Lucas, B. N. Sanchez, and J. M. Cerrato. 2021. Mine-site derived particulate matter exposure exacerbates neurological and pulmonary inflammatory outcomes in an autoimmune mouse model. J. Toxicol. Environ. Health Part A 84 (12):503–17. doi:https://doi.org/10.1080/15287394.2021.1891488.
- Xia, J., I. V. Sinelnikov, B. Han, and D. S. Wishart. 2015. MetaboAnalyst 3.0–making metabolomics more meaningful. Nucl Acids Res 1 (W1):W251–W257. doi:https://doi.org/10.1093/nar/gkv380.
- Yap, I. K., M. Angley, K. A. Veselkov, E. Holmes, J. C. Lindon, and J. K. Nicholson. 2010. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J. Proteome. Res 9 (6):2996–3004. doi:https://doi.org/10.1021/pr901188e.